BCTX - BriaCell signs supply agreement with Beigene for metastatic breast cancer treatment
2024-05-28 08:45:28 ET
More on Briacell Therapeutics, BeiGene, etc.
- BeiGene Still Bleeding Red Ink Despite Blockbuster Drug
- BriaCell falls on $5M stock offering
- BeiGene, AbbVie patent spat to get trial from USPTO appeals board
- Seeking Alpha’s Quant Rating on Briacell Therapeutics
- Historical earnings data for Briacell Therapeutics